{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:17:30Z","timestamp":1787959050598,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejpb.2023.114171","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T16:57:59Z","timestamp":1703782679000},"page":"114171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Competitive inhibition of nicotine acetylcholine receptors using microneedles of nicotine and varenicline for smoking withdrawal therapy"],"prefix":"10.1016","volume":"195","author":[{"given":"Ashwini","family":"Wani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-7645","authenticated-orcid":false,"given":"Pravin","family":"Shende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.114171_b0005","unstructured":"Tobacco [Internet]. [cited 2023 May 5]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco."},{"key":"10.1016\/j.ejpb.2023.114171_b0010","unstructured":"The Lancet & The Lancet Public Health: Latest global data finds nearly 8 million deaths from smoking in 2019, and 90% of new smokers addicted by age 25 | Institute for Health Metrics and Evaluation [Internet]. [cited 2023 May 5]. Available from: https:\/\/www.healthdata.org\/news-release\/lancet-lancet-public-health-latest-global-data-finds-nearly-8-million-deaths-smoking."},{"issue":"13\u201314","key":"10.1016\/j.ejpb.2023.114171_b0015","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1080\/10826080500294817","article-title":"Combination treatment for nicotine dependence: State of the science","volume":"40","author":"Ingersoll","year":"2005","journal-title":"Subst Use Misuse."},{"key":"10.1016\/j.ejpb.2023.114171_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"6","key":"10.1016\/j.ejpb.2023.114171_b0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/11536100-000000000-00000","article-title":"Combination pharmacotherapy for stopping smoking: What advantages does it offer?","volume":"70","author":"Ebbert","year":"2010","journal-title":"Drugs."},{"issue":"3","key":"10.1016\/j.ejpb.2023.114171_b0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JTO.0b013e318031bca4","article-title":"Treating tobacco dependence: Review of the best and latest treatment options","volume":"2","author":"Ebbert","year":"2007","journal-title":"Journal of Thoracic Oncology."},{"issue":"12","key":"10.1016\/j.ejpb.2023.114171_b0035","article-title":"Nicotine replacement therapy for smoking cessation","volume":"14","author":"Stead","year":"2017","journal-title":"Cochrane Database of Systematic Reviews."},{"issue":"12","key":"10.1016\/j.ejpb.2023.114171_b0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","article-title":"A review of the clinical pharmacokinetics and pharmacodynamics of Varenicline for smoking cessation","volume":"49","author":"Faessel","year":"2010","journal-title":"Clin Pharmacokinet."},{"issue":"April","key":"10.1016\/j.ejpb.2023.114171_b0045","article-title":"Polymeric microneedles for transdermal delivery of nanoparticles: Frontiers of formulation, sterility and stability aspects","volume":"65","author":"Salwa","year":"2021","journal-title":"J Drug Deliv Sci Technol."},{"issue":"14","key":"10.1016\/j.ejpb.2023.114171_b0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev."},{"key":"10.1016\/j.ejpb.2023.114171_b0055","doi-asserted-by":"crossref","unstructured":"ML. Blank J. Hoek M. George P. Gendall TS. Conner J. Thrul et al. An Exploration of Smoking-to-Vaping Transition Attempts Using a \u201cSmart\u201d Electronic Nicotine Delivery System. Nicotine & Tobacco Research [Internet]. 2019 Sep 19 [cited 2023 Sep 21];21 10 1339 46. Available from: 10.1093\/ntr\/nty093.","DOI":"10.1093\/ntr\/nty093"},{"key":"10.1016\/j.ejpb.2023.114171_b0060","unstructured":"Electronic Nicotine Delivery Systems (ENDS) Use | Division of Cancer Control and Population Sciences (DCCPS) [Internet]. [cited 2023 Sep 18]. Available from: https:\/\/cancercontrol.cancer.gov\/brp\/tcrb\/electronic-nicotine-delivery-systems."},{"key":"10.1016\/j.ejpb.2023.114171_b0065","doi-asserted-by":"crossref","unstructured":"Y. Huang J. Emery F. Naughton S. Cooper L. McDaid A. Dickinson et al. The development and acceptability testing of an app-based smart survey system to record smoking behaviour, use of nicotine replacement therapy (NRT) and e-cigarettes. BMC Res Notes [Internet]. 2022 Dec 1 [cited 2023 Sep 18];15 1 1 6. Available from: https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-022-05983-8.","DOI":"10.1186\/s13104-022-05983-8"},{"key":"10.1016\/j.ejpb.2023.114171_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2013.07.042","article-title":"Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism","author":"Tiwari","year":"2013","journal-title":"Free Radic Biol Med [Internet]."},{"key":"10.1016\/j.ejpb.2023.114171_b0075","doi-asserted-by":"crossref","DOI":"10.1039\/C9RA10857B","article-title":"PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: Effects of formulation parameters","author":"Hern\u00e1ndez-Giottonini","year":"2020","journal-title":"RSC Adv [internet]."},{"issue":"635","key":"10.1016\/j.ejpb.2023.114171_b0080","article-title":"Use of 3D applicator for intranasal microneedle arrays for combinational therapy in migraine","volume":"25","author":"Dali","year":"2023","journal-title":"Int J Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2023.114171_b0085","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat Protoc."},{"issue":"2","key":"10.1016\/j.ejpb.2023.114171_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpain.2010.06.011","article-title":"The influence of non-nociceptive factors on hot plate latency in rats","volume":"12","author":"Gunn","year":"2011","journal-title":"J Pain."},{"issue":"84","key":"10.1016\/j.ejpb.2023.114171_b0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.compositesa.2016.01.020","article-title":"Study of nanoparticles aggregation\/agglomeration in polymer particulate nanocomposites by mechanical properties","volume":"1","author":"Zare","year":"2016","journal-title":"Compos Part A Appl Sci Manuf."},{"key":"10.1016\/j.ejpb.2023.114171_b0100","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.freeradbiomed.2013.07.042","article-title":"Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism","volume":"65","author":"Tiwari","year":"2013","journal-title":"Free Radic Biol Med."},{"issue":"1","key":"10.1016\/j.ejpb.2023.114171_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-5362.199041","article-title":"Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles","volume":"12","author":"Salatin","year":"2017","journal-title":"Res Pharm Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2023.114171_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-023-05690-w","article-title":"Structural parameters of nanoparticles affecting their toxicity for biomedical applications: A review","volume":"25","author":"Abbasi","year":"2023","journal-title":"J. Nanopart. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2023.114171_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/02652040500286110","article-title":"Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives","volume":"23","author":"Chung","year":"2008","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.ejpb.2023.114171_b0120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s13346-019-00699-y","article-title":"Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics","volume":"10","author":"Roces","year":"2020","journal-title":"Drug Deliv Transl Res."},{"issue":"597","key":"10.1016\/j.ejpb.2023.114171_b0125","article-title":"Formulation of stabilizer-free, nontoxic PLGA and elastin-PLGA nanoparticle delivery systems","volume":"15","author":"Stromberg","year":"2021","journal-title":"Int J Pharm."},{"issue":"169","key":"10.1016\/j.ejpb.2023.114171_b0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2021.10.009","article-title":"Application of armodafinil-loaded microneedle patches against the negative influence induced by sleep deprivation","volume":"1","author":"Zhu","year":"2021","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics."},{"issue":"3","key":"10.1016\/j.ejpb.2023.114171_b0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly (lactic-co-glycolic acid) controlled release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit Rev Ther Drug Carrier Syst."},{"issue":"10","key":"10.1016\/j.ejpb.2023.114171_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-021-06580-0","article-title":"Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies","volume":"32","author":"Dobhal","year":"2021","journal-title":"J Mater Sci Mater Med."},{"issue":"1","key":"10.1016\/j.ejpb.2023.114171_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ph11010028","article-title":"Low molecular weight chitosan-coated PLGA nanoparticles for pulmonary delivery of tobramycin for cystic fibrosis","volume":"11","author":"Al-Nemrawi","year":"2018","journal-title":"Pharmaceuticals."},{"issue":"3","key":"10.1016\/j.ejpb.2023.114171_b0150","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)."},{"issue":"138","key":"10.1016\/j.ejpb.2023.114171_b0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.05.025","article-title":"New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice","volume":"1","author":"Bagdas","year":"2018","journal-title":"Neuropharmacol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123003351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123003351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:00:39Z","timestamp":1744297239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123003351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"alternative-id":["S0939641123003351"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.114171","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Competitive inhibition of nicotine acetylcholine receptors using microneedles of nicotine and varenicline for smoking withdrawal therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.114171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114171"}}